CytoAstra has developed the Cytophone, which uses a non-invasive technology called In Vivo Photoacoustic Flow Cytometry. The Cytophone technology uses a transcutaneous laser that detects abnormal or infected cells in the veins of a patient’s hands at a depth of a few millimeters. The laser, pain free to the patient, detects highly-localized light-absorbing contrast agents identifying the diseased or infected cells.
Company Details
- Founded
- 2016
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cytoastra.com
Cytoastra Questions
Cytoastra's website is https://www.cytoastra.com
Cytoastra's LinkedIn profile is https://www.linkedin.com/company/cytoastra
Cytoastra's industry is
Biotechnology Research
Cytoastra's top competitors are
Neuropace,
Rush Enterprises, Inc,
Foundation Medicine,
Perthera,
Billiontoone,
Strata Oncology,
Neurotronik.
Cytoastra's categories are Biotechnology Research
Cytoastra's founding year is 2016
